What is the Impact Factor of Current Drug Safety?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Current Drug Safety is 1.20, ranking in quartile Q4 of Web of Science (ESCI).

Is Current Drug Safety indexed in Web of Science or Scopus?

Yes, Current Drug Safety is indexed in Web of Science (ESCI, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.285 (Q3) and an H-index of 46.

Who publishes Current Drug Safety and what is the Article Processing Charge (APC)?

Current Drug Safety is published by Bentham. The estimated Article Processing Charge (APC) is approximately $2,693 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q4Scopus Q3SCImago #17,745Hybrid

Current Drug Safety

Identifier (ISSN):1574-8863(Print)/2212-3911(Online)

•

Publisher:Bentham

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

1.2↑ +0.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Current Drug Safety

WoS Q4

Annual Impact Factor Metric

Current (2026):1.2

Scopus SJR & RankScopus Q3

0.285

#17,745

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

46 papers with at least that number of citations each

WoS: ESCIQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

34articles/year

2.9% Gold OA•85.45% Original Research

Aims & Scope

Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.

Topics Covered (Recognized by AI)

Medicine99.8%Biology89.8%Internal medicine80.9%Psychology57.9%Pharmacology54.6%Psychiatry52.9%Pathology51.2%Genetics45.4%Chemistry43%Surgery41.8%Biochemistry35%Endocrinology34.8%Adverse effect28.4%Immunology23.8%Drug23%Intensive care medicine21.7%Anesthesia21.3%

Primary Research Areas

Pharmacology & Pharmacy

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

PHARMACOLOGY & PHARMACY

Rank307/356

IndexESCI

JCIESCI2026

PHARMACOLOGY & PHARMACY

Rank296/356

IndexESCI

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRESCI	307/356	Q4
PHARMACOLOGY & PHARMACY	JCIESCI	296/356	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.2

Articles / Year45

Total Citations7

2025

IF0.7

Articles / Year60

Total Citations74

2024

IF1.1

Articles / Year57

Total Citations149

2023

IF1.5

Articles / Year65

Total Citations316

2022

IF—

Articles / Year99

Total Citations365

Year	Impact Factor	Articles / Year	Total Citations
2026	1.2	45	7
2025	0.7	60	74
2024	1.1	57	149
2023	1.5	65	316
2022	—	99	365
2021	—	60	243
2020	—	66	696
2019	—	47	634
2018	—	53	913
2017	—	38	296
2016	—	35	349
2015	—	69	1,072

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,745Scopus Q3SCImago Profile

Scopus Coverage:2006-2025

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q3

0.285

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.34

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,693 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations255

3-Year Documents209

Citable Documents204

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ3

Pharmacology (medical)Q3

ToxicologyQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Drug Safety (ISSN: 1574-8863) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Bentham in United Arab Emirates. The periodical holds a Journal Impact Factor (JIF) of 1.20, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.285 (Q3), an H-index of 46.

The journal enforces rigorous peer evaluation with an annual output of approximately 34 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,693 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.